C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2691357
Antibodies which block the binding of human Programmed Death Receptor 1(hPD-1) to its ligands (hPD-L1 or hPD-L2) and their variable region sequences are disclosed. A method of increasing the activity (or reducing downmodulation) of an immune response through the PD-I pathway is also disclosed.
L'invention porte sur des anticorps qui bloquent la liaison du Récepteur humain de Mort Programmée l(hPD-l) à ses ligands (hPD-Ll ou hPD-L2) et leurs séquences de région variable. L'invention porte sur un procédé d'augmentation de l'activité (ou de réduction de la modulation négative) d'une réponse immunitaire par la voie PD-I.
Carven Gregory John
Dulos Gradus Johannes
Van Eenennaam Hans
N.v. Organon
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Antibodies to human programmed death receptor pd-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to human programmed death receptor pd-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to human programmed death receptor pd-1 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1696783